Evicenter
Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) in Chronic obstructive pulmonary disease
Manufacturer
GlaxoSmithKline
Questions
32
Last updated

All questions

Safety: Trelegy Ellipta (fluticasone furoate, umeclidinium, and vilanterol inhalation powder) in chronic obstructive pulmonary disease

8 questions · 5 sources

Side effects

What side effects were reported with Trelegy in the IMPACT COPD trial?

Note: The table text lists each row's values in the header order: TRELEGY 100 (n=4151), BREO 100 (n=4134), ANORO (n=2070), as percentages. Pneumonia counted as an adverse event of special interest was 8% for TRELEGY 100.

What side effects were reported with Trelegy in the FULFIL trial?

Note: Each row lists TRELEGY 100 first and SYMBICORT TURBUHALER 400/12 second, as percentages. In the pneumonia table the 52-week row covers the extension population. SYMBICORT TURBUHALER 400/12 is a non-US budesonide/formoterol formulation.

What are the most common side effects of Trelegy for COPD?

Note: The first passage gives rates from two 12-week trials of umeclidinium added to fluticasone furoate/vilanterol, with the placebo + FF/VI rate in parentheses. The second is the label summary, which includes the 52-week trial.

What are the long-term side effects of Trelegy for COPD?

Note: The label's warnings on bone mineral density, glaucoma, and cataracts concern long-term ICS use; see the bone loss and glaucoma questions.

Warnings

Does Trelegy increase the risk of pneumonia in COPD?

Note: The 52-week trial is IMPACT (Trial 3 of the Prescribing Information).

Can Trelegy cause heart problems in COPD?

Note: The 52-week trial is IMPACT (Trial 3 of the Prescribing Information).

Does Trelegy cause bone loss in COPD?

Can Trelegy be started while COPD is rapidly worsening?